PMA PMA
Company Profile ↓Company Overview
PMA (PMA) is a publicly traded company listed on with a market capitalization of $17.65M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 33.0% CAGR over the past five years.
Recent Developments
- Mar 2025 Revenue of $33.85M (+22.8% YoY); net profit $-5.73M.
- Trailing 12 Months Year-on-year growth — revenue +22.8%, earnings -346.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 33.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 33.01% |
| 1 Year: | 22.77% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -346.31% |
Stock Price Performance
| 1 Year: | -4.90% |
| 6 Months: | +16.24% |
| 3 Months: | -13.38% |
| 1 Month: | +7.09% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Death Cross5d ago
- RSI (14)52.29 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 33.0% over 5 years.
CONS
- Trading 54.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 14.38M | 21.87M | 27.57M | 33.85M |
| Cost of Revenue | 11.76M | 18.37M | 22.48M | 35.16M |
| Gross Profit | 2.63M | 3.49M | 5.09M | -1.31M |
| Operating Expenses | 497.82K | 832.55K | 1.21M | 2.00M |
| Operating Income | 2.13M | 2.66M | 3.89M | -3.30M |
| EBITDA | 2.25M | 3.52M | 3.37M | -5.15M |
| Interest Expense | 74.57K | 179.99K | 286.09K | 508.81K |
| Pretax Income | 2.12M | 3.26M | 2.98M | -5.81M |
| Tax Provision | 317.10K | 468.89K | 648.94K | -80.15K |
| Net Income | 1.80M | 2.79M | 2.33M | -5.73M |
| Diluted EPS | 0.14 | 0.19 | 0.18 | -0.48 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | 5.60M | 8.28M | 11.89M | 13.42M |
| Current Assets | 5.18M | 6.92M | 8.84M | 10.26M |
| Cash & Equivalents | 217.79K | 323.96K | 1.08M | 249.92K |
| Inventory | - | - | - | - |
| Receivables | 3.77M | 3.32M | 1.64M | 4.22M |
| Total Liabilities | 5.44M | 7.90M | 10.89M | 12.44M |
| Current Liabilities | 3.96M | 6.18M | 7.74M | 9.53M |
| Long Term Debt | 1.39M | 1.50M | 3.03M | 2.87M |
| Total Debt | 3.15M | 5.62M | 7.03M | 7.74M |
| Total Equity | 159.76K | 382.89K | 998.26K | 983.98K |
| Shares Outstanding | 12.75M | 12.75M | 12.75M | 12.97M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -151.56K | 795.33K | 2.46M | -7.97M |
| Investing Cash Flow | 56.39K | 35.90K | -1.15M | 10.26K |
| Financing Cash Flow | -1.58K | -725.06K | -553.37K | 7.13M |
| Capital Expenditure | - | -15.38K | -1.15M | - |
| Free Cash Flow | -151.56K | 779.94K | 1.31M | -7.97M |
| Net Change in Cash | -96.75K | 106.17K | 756.56K | -830.59K |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Gross Margin % | 18.3% | 16.0% | 18.5% | -3.9% |
| Operating Margin % | 14.8% | 12.2% | 14.1% | -9.8% |
| Net Margin % | 12.5% | 12.7% | 8.4% | -16.9% |
| ROE % | 1,128.9% | 727.9% | 233.1% | -582.4% |
| ROCE % | 130.0% | 126.7% | 93.7% | -84.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PMA
PMA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFAzdWF6RU5HQ0RHSXFqWmd1eFZkZ3BrMFVCek55dGxfWDFwN1BfSDJHeTRNbjlKTE5rdTY0U1Judy02eDVtbWlYVk5mQV9KM1RxRFE?oc=5" target="_blank">PMA Stock News Today | Earnings, Events & Price Alerts</…
PMA | Ming Shing Group Holdings Stock Data, Price & News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1aNDZRbURWMnh6ckU3RDBzbUFfb2wxanpPMVljZm5seXNkU0pEenhkdThGbkJZbWlMazlwME1LaDktT1JMdWxfeW9ta05FaFU?oc=5" target="_blank">PMA | Ming Shing Group Holdings Stock Data, Price & News</a>…
Ming Shing Group Holdings (PMA) Stock News - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiTEFVX3lxTE41cWlyaUtXczVfdGdRRU1JZnUxSHNBTnVxRkNSRGtCVUFWZ3dPeTk4bC1rcFZIZHdmZUhlQ2N4alRkZjZoNmJYbGRJa1o?oc=5" target="_blank">Ming Shing Group Holdings (PMA) Stock News</a> <font …
Price to book forward of Prima Moda S.A. – GPW:PMA - TradingView
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNY1ViR24zR1BWYUpiR1pyUDk4OXRlZjlQZEtjUTJWLV9IV3Nab244NF9aRXhtVGZXb2FKT0hzdkVneldoVkNSZnpSekNIaEloRzF2eUZKZDdkMkZvdWdIVDlMVDMyWE45TFl2bzNISHdibERsMW1FN1FYT2U5cWM0VEFGNjJzN1ZQOU9RZk…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFByVkd2TWs0ak5GZkZIcmZGaksyMTZwMWZhQ0h5MldXb0ZnYnliakhsTHVyVUZpSTQzWklReWw4RmdINm9RdzQ1VTI1RjFvdVU?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <font…
PMA Technical Analysis & Stock Price Forecast - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE5ObmlJcjlGVXFmUjlrYzZZVmtNWFcwSkJ5WS1PbmR3Vk54SkNtVlFWUFViU2J3ZmNqQ2MwZC0yenc3a3VteEtnN0VKX3JreHJrSkVWbg?oc=5" target="_blank">PMA Technical Analysis & Stock Price Forecast</a>&nbs…
PMA — Frequently Asked Questions
What is the current share price of PMA?
As of 2026-08-05 17:25 PDT, PMA trades at $1.36 on NASDAQ/NYSE. Its 52-week range is $0.73 to $2.97.
What is the market capitalisation of PMA?
PMA has a market capitalisation of $17.65M on NASDAQ/NYSE.
What is the P/E ratio of PMA?
PMA trades at a trailing price-to-earnings (P/E) ratio of -2.83. Its price-to-book (P/B) ratio is 17.94.
Is PMA a good stock to buy?
This page provides a data-driven analysis of PMA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.